Vol 6, No 3 (2010)

Cover Page

DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS. URINARY BLADDER CANCER

NONINVASIVE DIAGNOSIS OF URINARY BLADDER CANCER BY CROSS-POLARIZATION OPTICAL COHERENCE TOMOGRAPHY: CLINICAL RESULTS

Streltsova O.S., Gladkova N.D., Kiseleva E.B., Karabut M.M., Tararova E.A., Yunusova K.E., Krupin V.N., Zagainova E.V.

Abstract

The investigation examined the feasibility of cross-polarization optical cohe-rence tomography (CP OCT) to detect early urinary bladder cancer (UBC). Studies were performed in 376 patients; 5290 images were obtained using an OCT 133-U optical coherence tomograph. To acquire and compare intrared-light scattering images in baseline and orthogonal polarizations is the basis of CP OCT; their analysis makes it possible to judge from the state of the epithelium/connective tissue system and to obtain information on changes in tissue depolarizing components, collagen in particular. The authors elaborated criteria as determinants of the nature of CP OCT changes in direct and orthogonal polarizations in health, inflammatory changes, and UBC at its early stage - urothelial dysplasia and carcinoma in situ in flat suspected areas.
Cancer Urology. 2010;6(3):25-31
pages 25-31 views

DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS. RENAL CANCER

THE ACTIVITY OF PROTEASOMES AND THEIR SUBUNIT COMPOSITION IN CANCER OF THE KIDNEY AND URINARY BLADDER

Spirina L.V., Kondakova I.V., Usynin E.A., Sharova N.P.

Abstract

The study revealed a reduction in the chemotrypsin-like activity of the total pool of proteasomes and their 26S and 20S pools in the tissue of clear-cell carcinoma of the kidney versus intact tissue. Renal cancer tissue was found to contain the higher levels of the proteasome subunits α1α2α3α5α6α7 than did intact tissues, which was accompanied by the lower content of the subunits LMP2 and PA28β. A urinary bladder tumor showed the enhanced activity of the 26S proteasomes and the lower expression of α1α2α3α5α6α7 and the elevated level of the LMP2 subunit as part of proteasomes. Intact renal tissue 26S proteasome activity was found to be related to late tumor spread. Urinary bladder cancer tissue showed a correlation between the expression of the proteasome subunits α1α2α3α5α6α7 and the size of a tumor and that between 26 proteasome activity and the degree of histological tumor differentiation.
Cancer Urology. 2010;6(3):12-15
pages 12-15 views

SYNCHRONOUS UROTHELIAL AND RENAL CELL CARCINOMAS: A REVIEW OF LITERATURE AND CLINICAL NOTES

Afonin S.V., Matveyev V.B., Tyurin I.E.

Abstract

Synchronous renal cell and urothelial carcinomas are rare in the same patient. The paper describes the epidemiology, diagnosis, and treatment of the given type of pathology and presents the data of the authors observations and the specific features of each specific case.
Cancer Urology. 2010;6(3):16-18
pages 16-18 views

EVEROLIMUS IN THE TREATMENT FOR METASTATIC RENAL CANCER

Alekseyev B.Y., Kalpinsky A.S.

Abstract

Cancer Urology. 2010;6(3):19-24
pages 19-24 views

REVIEW

TREATMENT IN PATIENTS WITH MUSCLE NONINVASIVE CARCINOMA OF THE URINARY BLADDER AFTER UNSUCCESSFUL INTRAVESICULAR BCG THERAPY

Figurin K.M.

Abstract

Failures of BCG therapy for muscle noninvasive carcinoma of the urinary bladder are classified as BCG refractoriness, BCG resistance, postBCG-therapy recurrences. Some patients are observed to be BCG intolerant, which makes the therapy discontinued. Detectable BCG refractoriness and early recurrences are associated with a high risk of progression and high tumor-specific mortality and are indications for emergency cystectomy. Preference should be given to early cystectomy if high risk group patients have additional poor prognostic factors for disease progression. In patients with BCG therapy failures, medical treatment should be performed only within research programs.
Cancer Urology. 2010;6(3):51-56
pages 51-56 views

NEW METHODS FOR PREDICTING THE SENSITIVITY OF RENAL CANCER TO IMMUNOTHERAPY ON THE BASIS OF ANALYSIS OF MOLECULAR GENETIC CHARACTERISTICS OF A TUMOR

Aivazov M.T., Bozhenko V.K., Kaprin A.D.

Abstract

The paper reviews the literature on the treatment of renal cancer, mainly on postoperative immunotherapy. It outlines a role of cytokines in tumor-immune system interaction, the prognostic value of the level of expression of each cytokine for both survival rates and the efficiency of immunotherapy, as well as the use of this information to develop new therapeutic approaches.
Cancer Urology. 2010;6(3):57-62
pages 57-62 views

PROSTATE CANCER

THE FIRST EXPERIENCE IN USING THE ULTRASOUND AND MAGNETIC RESONANCE IMAGE FUSION TECHNOLOGY IN THE DIAGNOSIS OF PROSTATE CANCER

Kapustin V.V., Shirokorad V.I., Gromov A.I., Koshurnikov D.S.

Abstract

Objective: to study the feasibility of the image fusion technology to choose a target portion for needle biopsy in prostate cancer (PC). Subjects and methods. Ultrasound (US)-magnetic resonance imaging (MRI)-guided needle biopsies were made in 12 patients. All the patients underwent intravenous bolus-enhanced MRI, then MRI and US images were fused during transrectal ultrasound studies (TRUS) and targets were determined to make a needle biopsy. Results. The image fusion technology allows one to concurrently assess MRI and US images in the primary diagnosis of prostate cancer and after radical prostatectomy (RPE). The MRI and transrectal images are compared with a high degree of accuracy, providing the clear positioning of the portions substantially accumulating the MRI contrast agent during real-time TRUS. Conclusion. The MRI-US image fusion procedure enables the choice of the targets to be biopsied both in the primary diagnosis of PC and in its suspected recurrence in patients after RPE. The increased accumulation of a MRI contrast agent is a major criterion for choosing a target portion.
Cancer Urology. 2010;6(3):32-36
pages 32-36 views

ROBOT-ASSISTED RADICAL PROSTATECTOMY: ANALYSIS OF THE FIRST 80 CASES

Pushkar D.Y., Rasner P.I., Kolontarev K.B.

Abstract

Background. As a common disease, prostate cancer (PC) has taken now first place among all malignancies in many countries of the world.The authors have analyzed the results of their series of robot-assisted radical laparoscopic prostatectomy (RALP) in patients with PC. They also present a number of surgical techniques that may be useful for novice surgeons. Materials and methods. In November 2008 to November 2009, the Department of Urology, Moscow State University of Medicine and Dentistry, performed 80 RALPs using the da Vinci S surgical robotic system. The patients’ mean age was 63.7 (49–71) years; the mean blood level of total prostate-specific antigen was 6.1 (2.1–20.84) ng/ml; the mean prostate volume was 44 (18–94) cm3, as evidenced by transrectal ultrasound study. The authors analyzed the following indicators: operating time, degree of blood loss, conversion of surgical intervention,degrees of intra- and postoperative complications, and oncological and functional results. Results. In our series, RALP was performed without preserving neurovascular bundles or by using a nerve-sparing procedure in 66 (82.5%) and 14 (17.5%), respectively; 22 (27.5%) patients underwent lymphadenectomy. The average length of hospital stay was 7 (4–21) days; the mean time of urethral catheter removal was 10 (6–21) days postoperatively. The mean time of surgical intervention was 174 (121–276) min. Mean blood loss was 248 (35–1950) ml. Postmortem study revealed a positive surgical margin in 19 (24%) cases and tumor invasion into the seminal vesicles in 5 (6%) patients. Stages pT2 and pT3 were found in 56 (70%) and 24 (30%), respectively; total Gleason scores were 6 (3+3), 7 (3+4), 7 (4+3), 8 (4+4) in 38 (47.5%), 35 (43.75%), 5 (6.25%), and 2 (2.5%) patients, respectively. Among 34 patients examined 3 months after RALP, 28 (82.4%) patients completely retained urine; 5 (14.7%) applied not more than a pad a day. In patients with preserved erectile function, the latter cannot be presently evaluated because the follow-up was short and operations performed by a nervesparing procedure were few. Conclusion. The results of analyzing our series of RALP, by using the da Vinci S surgical robotic system, are similar to those of analyzing the first experience with such interventions performed by foreign colleges. By taking into account a small number of our cases analyzed, it is difficult to speak reliably about complications caused by RALP. Studies involving a large number of cases are needed to reliably estimate these findings and to analyze a postoperative period and functional results.

Cancer Urology. 2010;6(3):37-42
pages 37-42 views

EARLY POSTOPERATIVE HOMEOSTATIC CHANGES AFTER TRANSURETHRAL RESECTION OF THE PROSTATE AND WAYS OF PREVENTING COMPLICATIONS

Volkov D.Y., Artifeksov S.B., Artifeksova A.A.

Abstract

The found changes in the blood coagulation system, serum and prostate tissue spectral analysis, and immunological changes show the development of occult disseminated intravascular coagulation and systemic inflammatory responses caused by endothelial damage, microcirculatory disorders, lipid peroxidation, and release of inflammatory factors. The findings will allow one to elaborate a tactic for medical prevention of complications.
Cancer Urology. 2010;6(3):43-47
pages 43-47 views

PREDICTION OF COMPLICATIONS DUE TO INTRATISSUE RADIOTHERAPY IN MULTIMODALITY TREATMENT FOR PROSTATE CANCER

Kostin А.А., Semin A.V., Kaprin A.D., Tsybulsky A.D.

Abstract

The study of postbrachytherapy complications identified a number of factors that significantly influenced the development of lower urinary tract (LUT) complications. These factors may include prostate volume and preoperative degree of LUT symptoms. The combined effect of these factors increases a risk for the complications.
Cancer Urology. 2010;6(3):48-50
pages 48-50 views

CONGRESSES AND CONFERENCES

ОБЗОР МАТЕРИАЛОВ 25-ГО ЕЖЕГОДНОГО КОНГРЕССА ЕВРОПЕЙСКОЙ АССОЦИАЦИИ УРОЛОГОВ

.

Abstract

Обзор материалов 25-го ежегодного конгресса Европейской ассоциации урологов

Cancer Urology. 2010;6(3):63-67
pages 63-67 views

LECTURE

TREATMENT FOR STAGE I TESTICULAR SEMINOMA

Burova E.A., Bulanov A.A., Tryakin A.A., Fedyanin M.Y., Tyulyandin S.A., Matveyev V.B.

Abstract

Overall survival is about 100% in patients with stage I germinogenic testicular tumors after orchifuniculectomy, which is achieved, by applying alternative adjuvant approaches. The use of approaches, such as a follow-up, chemo- and radiotherapy, may be recommended in seminoma. The paper shows the advantages and disadvantages of these methods.
Cancer Urology. 2010;6(3):7-11
pages 7-11 views